Here are relevant reports on : horticultural-substrates-market
-
Printed Electronics Market by Printing Technology (Screen, Inkjet, Flexographic, Gravure Printing), Material (Inks, Substrates), Resolution (Below 100 Lines/CM, 100-200 Lines/CM, Above 200 Lines/CM) and Geography - Global Forecast to 2030
The global printed electronics market is expected to grow from USD 19.46 billion in 2025 to USD 39.85 billion by 2030, at a compound annual growth rate (CAGR) of 15.4% during the forecast period. The Key Players DuPont (US), BASF (Germany), Agfa-Gevaert Group (Belgium), Henkel AG & Co. KGaA (Germany), and NovaCentrix (US).
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Global Forecast to 2022
The BRIC IVD Market and other emerging countries is expected to reach USD 15.71 Billion by 2022 from USD 10.60 Billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in some emerging countries.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China
The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.
- Published: April 2010
- Price: $ 4950
- TOC Available:
-
OLED Market Size, Share, Industry Growth, Trends & Analysis by Product Type (Smartphones, Television Sets, Smart Wearables, Large Format Displays), Panel Type, Panel Size, Technology, Vertical, and Geography
The OLED Market is expected to grow from USD 38.4 billion in 2021 to USD 72.8 billion by 2026, at a CAGR of 13.6% during the forecast period. A few of the key players in the OLED market are Samsung Electronics (South Korea), LG Display (South Korea), BOE Technology (China), AU Optronics (Taiwan), Universal Display Corporation (US), and Tianma Microelectronics (China).
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
Global Breast Cancer Drugs Market
There are about one million new cases of breast cancer every year. Breast cancer accounts for about 10% of world wide cancer. There has been significant increase in awareness levels with respect to impact on survival rates incase of early diagnosis. Therefore, opening novel opportunities for breast cancer drugs market.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma, Colorectal), Product (Instruments, Consumables), Application (Diagnostics, R&D, Prognostics), End-user, and Region - Global Forecast to 2029
The global cancer biomarkers market, valued at US$22.3 billion in 2023, stood at US$24.5 billion in 2024 and is projected to advance at a resilient CAGR of 11.3% from 2024 to 2029, culminating in a forecasted valuation of US$42.0 billion by the end of the period. The primary drivers of growth in this market are the rising incidence of cancer worldwide, increased research on cancer biomarkers, the growing use of biomarkers in drug discovery and development, and ongoing technical advancements.
- Published: April 2024
- Price: $ 7150
- TOC Available:
-
Global Ophthalmology Drugs & Devices Market
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
- Published: May 2010
- Price: $ 4950
- TOC Available:
-
Mobile Phone & Smartphone Market Global Forecast (2010-2015)
The report aims at providing extensive market intelligence on the smartphones market, which is currently witnessing high growth due to a host of factors, including lower product cost, improved handset design and functionalities, the expansion of global mobile email and browsing services, the emergence of 3G and 4G network technologies, the rising competition among mobile carriers, and the standardization and upgrades of operating systems.
- Published: February 2011
- Price: $ 4950
- TOC Available:
-
Global Colorectal Cancer Market (2010-2015)
2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Global Multiple Myeloma Drugs Market
2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate. There has been a significant development in technologies and drugs/vaccines with respect to breast cancer, thyroid cancer, and pancreatic cancer therefore increasing the survival rates.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
